Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lagier, J.-C., Armougom, F., Million, M., Hugon, P., Pagnier, I., Robert, C., Bittar, F., Fournous, G., Gimenez, G., Maraninchi, M., Trape, J.-F., Koonin, E. V., La Scola, B., & Raoult, D. (2012). Microbial culturomics: paradigm shift in the human gut microbiome study. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 18(12), 1185–1193.
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: human ear and human faeces
DNA G+C(%): 38-39
|
Opt. T: 30-40℃
Low T(℃): 15(neg)
Lower T(℃): 20(+)
High T(℃): 45(+)
NaCl >6%: 10(+)
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
Augmentin: S(≤1/2)
ampicillin: Var(MIC50): 6.25, MIC90: 25, RNG: (0.05-200)
oxacillin: Var(MIC50): >2, MIC90: >2, RNG: (≤0.06->2)
piper-taz: S(≤2/≤2)
ertapenem: S(0.5/4)
|
|
gentamicin: Var(MIC50): 6.25, MIC90: 50, RNG: (0.05-200)
streptomycin: Var(MIC50): 3.12, MIC90: 12.5, RNG: (0.78-12.5)
|
quin-dalf: S(MIC50): 0.25, MIC90: 0.5, RNG: (≤0.25->8)
|
linezolid: S(MIC50): 1, MIC90: 1, RNG: (0.12-2)
levofloxacin: Var(MIC50): >2, MIC90: >4, RNG: (≤0.03->4)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
doxycycline: S(≤2/4)
tetracycline: Var(MIC50): >2, MIC90: >8, RNG: (≤2->8)
tigecycline: S(MIC50): 0.25, MIC90: 0.5, RNG: (0.03-1)
|
teicoplanin: Var(MIC50): 2, MIC90: 8, RNG: (≤2->16)
vancomycin: S(MIC50): 1, MIC90: 2, RNG: (0.25-4)
|
|
chloramphenicol: R(MIC50): 12.5, MIC90: 100, RNG: (0.05->200)
SXT: S(≤0.5/1)
co-trimoxazole: S(MIC50): >1, MIC90: >2, RNG: (≤0.5->2)
|
clindamycin: Var(MIC50): >0.12, MIC90: >8, RNG: (≤0.06->8)
daptomycin: S(MIC50): 0.25, MIC90: 0.5, RNG: (0.06-2)
novobiocin: Sens
|